Demonstration of therapeutic equivalence of generic and innovator beclomethasone in seasonal allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 5, 1999, Pages 435-441

  Casale, Thomas B ^b   Azzam, Sara M ^b   Miller, Randall E ^a   Oren, Joseph ^a   Bukstein, Don A ^b   Busse, William W ^b   Korenblatt, Phillip ^b   Lumry, William R ^b   Silvagni, Anthony J ^b   Stricker, William E ^b   Vandewalker, Mark ^b  

^a Dey Laboratories   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; GENERIC DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SNEEZING;

EID: 0033007659     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62717-2     Document Type: Article

References (11)

1. Salvaggio JE. Allergic rhinitis. In: Wyngaarden JB, Smith LH, Bennett JC. Cecil textbook of medicine 1992; 19th edition. Philadelphia, WB Saunders Company.
2. Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993;48:476-490.
3. Bryson HM, Faulds D. Intranasal fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992;43: 760-775.
4. Meltzer EO. The prevalence and medical and economic impact of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99: S805-S828.
5. Chrystyn H. Standards for bioequivalence of inhaled products. Clin Pharmacokinet 1994;26:1-6.
6. FDA Division of Oncology and Pulmonary Drug Products. Points to consider: clinical development program for MDI and DPI drug products, September 19, 1994.
7. Meltzer EO, Schatz M. Pharmacotherapy of rhinitis: 1987 and beyond. Immunol Allergy Clin North Am 1987;7: 57-91.
8. Naclerio RM. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol 1988;82:927-934.
9. Bousquet J, Chanal I, Alquie MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. Allergy 1993;48:327-333.
10. Pipkorn U, Proud D, Lichtenstein LM, et al. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticoids. N Engl J Med 1987;316:1506-1510.
11. Bernstein DI, Creticos PS, Busse WW, et al. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996;97:749-755.